Arcus Biosciences, Inc. (RCUS) quarterly income statement — complete revenue, gross profit & net income history
Arcus Biosciences, Inc. (RCUS) annual income statement — 10-year revenue, gross profit & net income history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Sales/Revenue | 41M | 17M | 33M | 26M | 160M | 28M | 26M | 48M | 39M | 145M | 31M | 32M | 29M | 25M | 33.66M | 33M | 27M | 18M | 354.5M | 9.46M |
| Revenue Growth % | -74.38% | -39.29% | 26.92% | -45.83% | 310.26% | -80.69% | -16.13% | 50% | 34.48% | 480% | -7.89% | -3.03% | 7.41% | 38.89% | -90.51% | 248.8% | 185.38% | 90.25% | 3636.68% | -85.34% |
| Cost of Goods Sold | 0 | 2M | 3M | 2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | 11.76% | 9.09% | 7.69% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 41M | 15M | 30M | 24M | 160M | 28M | 26M | 48M | 39M | 145M | 31M | 32M | 29M | 25M | 33.66M | 33M | 27M | 18M | 354.5M | 9.46M |
| Gross Margin % | 100% | 88.24% | 90.91% | 92.31% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | -74.38% | -46.43% | 15.38% | -50% | 310.26% | -80.69% | -16.13% | 50% | 34.48% | 480% | -7.89% | -3.03% | 7.41% | 38.89% | -90.51% | 248.8% | 185.38% | 90.25% | 3636.68% | -85.34% |
| Operating Expenses | 137M | 149M | 144M | 166M | 168M | 150M | 129M | 153M | 145M | 161M | 122M | 112M | 112M | 111M | 108.1M | 103M | 96M | 85M | 73.23M | 87.6M |
| OpEx % of Revenue | 334.15% | 876.47% | 436.36% | 638.46% | 105% | 535.71% | 496.15% | 318.75% | 371.79% | 111.03% | 393.55% | 350% | 386.21% | 444% | 321.19% | 312.12% | 355.56% | 472.22% | 20.66% | 925.87% |
| Selling, General & Admin | 24M | 29M | 26M | 27M | 29M | 28M | 28M | 30M | 30M | 32M | 29M | 30M | 28M | 30M | 27.9M | 26M | 26M | 24M | 23.3M | 16.34M |
| SG&A % of Revenue | 58.54% | 170.59% | 78.79% | 103.85% | 18.13% | 100% | 107.69% | 62.5% | 76.92% | 22.07% | 93.55% | 93.75% | 96.55% | 120% | 82.89% | 78.79% | 96.3% | 133.33% | 6.57% | 172.74% |
| Research & Development | 113M | 122M | 121M | 141M | 139M | 122M | 101M | 123M | 115M | 109M | 93M | 82M | 84M | 81M | 80.2M | 77M | 70M | 61M | 49.94M | 71.25M |
| R&D % of Revenue | 275.61% | 717.65% | 366.67% | 542.31% | 86.88% | 435.71% | 388.46% | 256.25% | 294.87% | 75.17% | 300% | 256.25% | 289.66% | 324% | 238.3% | 233.33% | 259.26% | 338.89% | 14.09% | 753.13% |
| Other Operating Expenses | 0 | -1000K | -1000K | -1000K | 0 | 0 | 0 | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -96M | -134M | -114M | -142M | -8M | -122M | -103M | -105M | -106M | -16M | -91M | -80M | -83M | -86M | -74.44M | -70M | -69M | -67M | 281.27M | -78.14M |
| Operating Margin % | -234.15% | -788.24% | -345.45% | -546.15% | -5% | -435.71% | -396.15% | -218.75% | -271.79% | -11.03% | -293.55% | -250% | -286.21% | -344% | -221.19% | -212.12% | -255.56% | -372.22% | 79.34% | -825.87% |
| Operating Income Growth % | -1100% | -9.84% | -10.68% | -35.24% | 92.45% | -662.5% | -13.19% | -31.25% | -27.71% | 81.4% | -22.24% | -14.29% | -20.29% | -28.36% | -126.47% | 10.41% | 9.37% | 7.9% | 640.77% | -5134.54% |
| EBITDA | -93M | -132M | -111M | -140M | -6M | -119M | -100M | -103M | -104M | -13M | -88M | -79M | -81M | -84M | -72.96M | -68M | -67M | -66M | 280.83M | -77.17M |
| EBITDA Margin % | -226.83% | -776.47% | -336.36% | -538.46% | -3.75% | -425% | -384.62% | -214.58% | -266.67% | -8.97% | -283.87% | -246.88% | -279.31% | -336% | -216.8% | -206.06% | -248.15% | -366.67% | 79.22% | -815.7% |
| EBITDA Growth % | -1450% | -10.92% | -11% | -35.92% | 94.23% | -815.38% | -13.64% | -30.38% | -28.4% | 84.52% | -20.61% | -16.18% | -20.9% | -27.27% | -125.98% | 11.89% | 11.04% | 8.27% | 659.5% | -3124.02% |
| D&A (Non-Cash Add-back) | 3M | 2M | 3M | 2M | 2M | 3M | 3M | 2M | 2M | 3M | 3M | 1M | 2M | 2M | 1.48M | 2M | 2M | 1M | -441K | 963K |
| EBIT | -88M | -125M | -84M | -132M | 2M | -111M | -92M | -91M | -93M | -3M | -80M | -68M | -74M | -77M | -66.9M | -65M | -66M | -67M | 281.92M | -77.97M |
| Net Interest Income | 5M | 6M | 17M | 7M | 8M | 10M | 10M | 13M | 13M | 12M | 11M | 11M | 9M | 8M | 6.98M | 5M | 2M | 0 | -260K | 161K |
| Interest Income | 8M | 9M | 31M | 10M | 10M | 11M | 12M | 14M | 13M | 13M | 11M | 12M | 9M | 9M | 7.54M | 5M | 3M | 0 | 0 | 161K |
| Interest Expense | 3M | 3M | 14M | 3M | 2M | 1M | 2M | 1M | 0 | 1M | 0 | 1M | 0 | 1M | 563K | 0 | 1M | 0 | 260K | 0 |
| Other Income/Expense | 5M | 6M | 16M | 7M | 0 | 10M | 9M | 13M | 13M | 12M | 11M | 11M | 9M | 8M | 6.98M | 5M | 2M | 0 | -84K | 161K |
| Pretax Income | -91M | -128M | -98M | -135M | -8M | -112M | -94M | -92M | -93M | -4M | -80M | -69M | -74M | -78M | -67.46M | -65M | -67M | -67M | 281.18M | -77.97M |
| Pretax Margin % | -221.95% | -752.94% | -296.97% | -519.23% | -5% | -400% | -361.54% | -191.67% | -238.46% | -2.76% | -258.06% | -215.63% | -255.17% | -312% | -200.45% | -196.97% | -248.15% | -372.22% | 79.32% | -824.17% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 1M | 0 | 0 | 0 | 1M | 2M | 1M | 2M | -4K | 0 | 0 | 1M | 1.81M | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | -1.06% | 0% | 0% | 0% | -1.25% | -2.9% | -1.35% | -2.56% | 0.01% | 0% | 0% | -1.49% | 0.65% | 0% |
| Net Income | -91M | -128M | -98M | -135M | -8M | -112M | -94M | -92M | -93M | -4M | -81M | -71M | -75M | -80M | -67.46M | -65M | -67M | -68M | 279.37M | -77.97M |
| Net Margin % | -221.95% | -752.94% | -296.97% | -519.23% | -5% | -400% | -361.54% | -191.67% | -238.46% | -2.76% | -261.29% | -221.88% | -258.62% | -320% | -200.43% | -196.97% | -248.15% | -377.78% | 78.81% | -824.17% |
| Net Income Growth % | -1037.5% | -14.29% | -4.26% | -46.74% | 91.4% | -2700% | -16.05% | -29.58% | -24% | 95% | -20.08% | -9.23% | -11.94% | -17.65% | -124.15% | 16.64% | 11.81% | 6.33% | 638.77% | -4379.64% |
| Net Income (Continuing) | -91M | -128M | -98M | -135M | -8M | -112M | -95M | -92M | -93M | -4M | -81M | -71M | -75M | -80M | -67.46M | -65M | -67M | -68M | 279.37M | -77.97M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.72 | -1.02 | -0.92 | -1.27 | 0.04 | -1.14 | -1.03 | -1.01 | -1.02 | -0.05 | -1.08 | -0.95 | -1.02 | -1.10 | -0.92 | -0.84 | -0.90 | -0.96 | 3.71 | -1.11 |
| EPS Growth % | -1758.99% | 10.53% | 10.68% | -25.74% | 104.25% | -2356.9% | 4.63% | -6.32% | 0% | 95.78% | -17.39% | -13.1% | -13.33% | -14.58% | -124.8% | 24.32% | 17.43% | 11.11% | 552.44% | -3800% |
| EPS (Basic) | -0.72 | -1.02 | -0.92 | -1.27 | 0.04 | -1.14 | -1.03 | -1.01 | -1.02 | -0.05 | -1.08 | -0.95 | -1.02 | -1.10 | -0.92 | -0.84 | -0.90 | -0.96 | 3.97 | -1.11 |
| Diluted Shares Outstanding | 126.1M | 125.4M | 107.4M | 106.5M | 106.5M | 98.4M | 91.7M | 91.4M | 91.1M | 86.2M | 75M | 74.6M | 73.2M | 73M | 72.6M | 72.24M | 71.81M | 71.19M | 75.36M | 70.11M |
| Basic Shares Outstanding | 126.1M | 125.4M | 107.4M | 106.5M | 106.1M | 98.4M | 91.7M | 91.4M | 91.1M | 86.2M | 75M | 74.6M | 73.2M | 73M | 72.6M | 72.2M | 71.8M | 71.19M | 70.4M | 70.11M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |